Polen Capital Management’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
GIM
ACM
BPC
SCM
RA
AWA
KCM
EIM
Polen Capital Management's SOPH Position: Q1 2026 in Review
Polen Capital Management sold out of SOPHiA GENETICS (SOPH) in Q1 2026, closing a stake of 21,738 shares — an estimated $102K sold.
Polen Capital Management first reported a position in SOPH in Q4 2025 and held it in 1 quarter. The position peaked at $102K in Q4 2025. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.
- Polen Capital Management reported no remaining SOPHiA GENETICS position as of Q1 2026 after selling out during the quarter.
- Polen Capital Management sold 21,738 SOPHiA GENETICS shares in Q1 2026, an estimated $102K.
- Polen Capital Management first reported a position in SOPHiA GENETICS in Q4 2025 and held it in 1 quarter.
- Polen Capital Management's SOPHiA GENETICS position peaked at $102K in Q4 2025.
- 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.
Based on Polen Capital Management's 13F filing for Q1 2026, filed 14 May 2026.